Cardiol Therapeutics Statistics
NASDAQ: CRDLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.8626-0.0201 (-2.28%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Cardiol Therapeutics by the numbers
Cardiol Therapeutics has a market capitalization of $110.1 million based on 127.69M shares outstanding. With trailing EPS of $-0.24, Cardiol Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 33.5% below its 50-day average and 33.8% below its 200-day average.
Average daily trading volume is 1.20M shares, or about $1.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CRDL valuation vs. peer median
| Metric | CRDL | Peer median | Difference |
|---|---|---|---|
| Market cap | $110.14M | $114.65M | -4% |
| Avg. volume | 1.20M | 1.32M | -9% |
Peer median across 8 companies: FATE, ARMP, ENGN, IVVD, MOLN, HUMA, IPHA, CMPX.
Valuation
- Market cap
- $110.14M
- EPS (TTM)
- $-0.24
- Shares outstanding
- 127.69M
Price and trading
- Previous close
- 0.8827
- Open
- 0.88
- Day range
- 0.8417 – 0.8952
- 52-week range
- 0.8417 – 2.34
- 52-week change
- -11.35%
- Beta
- —
- Volume
- 552.97K
- Average volume
- 1.20M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 110.14M
- Forward Pe
- -3.68
- Eps
- -0.24
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.34
- Week52 Low
- 0.84
- Avg Volume
- 1.20M
- Shares Outstanding
- 127.69M
- Ma50
- 1.30
- Ma200
- 1.30
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -63.14%
- Pct From52w Low
- 2.48%